<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.01">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.01" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-106356-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Creating a Common Platform for HIV Vaccine Research and HIV Care and Treatment Program</narrative>
   <narrative xml:lang="FR">&#xC9;tablissement d&apos;une plateforme commune de recherche sur le vaccin contre le VIH et d&apos;un programme de  traitement des personnes infect&#xE9;es par le VIH</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Deuxi&#xE8;me pays le plus touch&#xE9; par le VIH apr&#xE8;s l&apos;Afrique du Sud, le Nigeria, o&#xF9; l&apos;&#xE9;pid&#xE9;mie se caract&#xE9;rise par la complexit&#xE9; des sous-types de VIH, est une cible capitale pour la recherche visant &#xE0; &#xE9;valuer le vaccin contre le VIH. Cette subvention appuiera l&apos;&#xE9;tablissement d&apos;un partenariat r&#xE9;unissant l&apos;Institute of Human Virology du Nigeria (IHV-Nigeria), organisme de recherche national &#xE0; but non lucratif, et des collaborateurs en recherche clinique de l&apos;Universit&#xE9; d&apos;Ottawa en vue de la mise sur pied d&apos;un site de recherche clinique sur le VIH satisfaisant aux normes internationales et en mesure de mener des essais cliniques sur le vaccin contre le VIH. Le projet portera notamment sur le renforcement des capacit&#xE9;s cliniques, l&apos;&#xE9;thique de la recherche, la r&#xE9;glementation, la mobilisation communautaire, l&apos;&#xE9;tablissement de cohortes &#xE0; risque et la recherche clinique, en plus de l&apos;am&#xE9;lioration des installations de laboratoire clinique afin que celles-ci satisfassent aux exigences de certification internationales. L&apos;id&#xE9;e consiste &#xE0; mettre sur pied une unit&#xE9; d&apos;essais cliniques enti&#xE8;rement fonctionnelle dans un milieu dynamique, le tout dans un solide cadre &#xE9;thique et r&#xE9;glementaire.</narrative>
   <narrative xml:lang="EN">Second only to South Africa in HIV burden, Nigeria&apos;s complex epidemic of HIV viral subtypes is a vital target for HIV vaccine evaluation research. This grant will support a partnership between the Institute of Human Virology-Nigeria (IHV-Nigeria) - a not-for-profit indigenous research organization - and clinical research collaborators from the University of Ottawa to create an internationally certified HIV clinical research site capable of conducting HIV vaccine clinical trials. This will involve capacity building in clinical practice, research ethics, regulation, community mobilization, risk cohort development and clinical research, plus strengthening clinical laboratory facilities to the level of international certification. The idea is to achieve a fully functional clinical trials unit within a well engaged community and robust ethical and regulatory infrastructure.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
   <narrative xml:lang="EN">Canadian International Development Agency</narrative>
  </participating-org>
  <participating-org role="2" type="23">
   <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
  </participating-org>
  <participating-org role="4" type="23">
   <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2010-09-30" type="2"></activity-date>
  <activity-date iso-date="2014-12-31" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="3"></activity-scope>
  <recipient-region code="XF" percentage="100" vocabulary="1"></recipient-region>
  <sector code="00003" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Children and Youth</narrative>
   <narrative xml:lang="FR">Enfants et jeunes</narrative>
  </sector>
  <sector code="13040" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="101" significance="2" vocabulary="99"></policy-marker>
  <policy-marker code="102" significance="0" vocabulary="99"></policy-marker>
  <policy-marker code="103" significance="0" vocabulary="99"></policy-marker>
  <policy-marker code="104" significance="1" vocabulary="99"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2010-11-30"></transaction-date>
   <value currency="CAD" value-date="2010-11-30">30442.61</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2010-11-30"></transaction-date>
   <value currency="CAD" value-date="2010-11-30">3894.4</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2011-03-31"></transaction-date>
   <value currency="CAD" value-date="2011-03-31">3894.4</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2011-11-30"></transaction-date>
   <value currency="CAD" value-date="2011-11-30">-3620.08</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2012-02-29"></transaction-date>
   <value currency="CAD" value-date="2012-02-29">3337.63</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2012-03-31"></transaction-date>
   <value currency="CAD" value-date="2012-03-31">3337.62</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2013-09-30"></transaction-date>
   <value currency="CAD" value-date="2013-09-30">1574.8</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2014-02-28"></transaction-date>
   <value currency="CAD" value-date="2014-02-28">4736.65</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2014-06-30"></transaction-date>
   <value currency="CAD" value-date="2014-06-30">3414.74</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2014-11-30"></transaction-date>
   <value currency="CAD" value-date="2014-11-30">1353.39</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2015-03-31"></transaction-date>
   <value currency="CAD" value-date="2015-03-31">1278.89</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2010-11-30"></transaction-date>
   <value currency="CAD" value-date="2010-11-30">1319557.38</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2010-11-30"></transaction-date>
   <value currency="CAD" value-date="2010-11-30">168805.6</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2011-03-31"></transaction-date>
   <value currency="CAD" value-date="2011-03-31">168805.6</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2011-11-30"></transaction-date>
   <value currency="CAD" value-date="2011-11-30">3620.09</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2012-02-29"></transaction-date>
   <value currency="CAD" value-date="2012-02-29">172822.37</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2012-03-31"></transaction-date>
   <value currency="CAD" value-date="2012-03-31">172822.38</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2013-09-30"></transaction-date>
   <value currency="CAD" value-date="2013-09-30">81543.2</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2014-02-28"></transaction-date>
   <value currency="CAD" value-date="2014-02-28">245263.35</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2014-06-30"></transaction-date>
   <value currency="CAD" value-date="2014-06-30">176815.26</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2014-11-30"></transaction-date>
   <value currency="CAD" value-date="2014-11-30">70078.61</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2015-03-31"></transaction-date>
   <value currency="CAD" value-date="2015-03-31">66221.11</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Institute of Human Virology Nig Ltdgte</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
